Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDHCW Biologics Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.18 | -$0.18 | -$0.18 |
| Q2 2024 | 1 | -$0.13 | -$0.13 | -$0.13 |
| Q3 2024 | 1 | $0.09 | $0.09 | $0.09 |
HCW Biologics Inc. Earnings Date And Information
HCW Biologics Inc. last posted its earnings results on Thursday, November 14th, 2024. The company reported $-0.1 earnings per share for the quarter, topping analysts' consensus estimates of $-0.13 by $0.03. The company had revenue of 426,423 for the quarter and had revenue of 2.84 M for the year. HCW Biologics Inc. has generated $-1 earnings per share over the last year ($-0.7 diluted earnings per share) and currently has a price-to-earnings ratio of -0.4. HCW Biologics Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, April 1st, 2025 based on prior year's report dates.
HCW Biologics Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2024 | Q3 2024 | -$0.13 | -$0.10 | 0.03 | $426,423 | $426,423 |
| 08/14/2024 | Q2 2024 | -$0.40 | $618,854 | $618,854 | ||
| 05/15/2024 | Q1 2024 | -$0.20 | $1.13 M | |||
| 05/15/2024 | Q4 2023 | -$0.30 | $1.32 M | |||
| 09/29/2023 | Q3 2023 | -$0.14 | $600,000 | $853,102 | ||
| 08/11/2023 | Q2 2023 | -$0.15 | -$0.12 | 0.03 | $622,807 | |
| 08/10/2023 | Q1 2023 | -$0.14 | $41,883 | |||
| 03/28/2023 | Q4 2022 | $0.16 | -$0.15 | -0.31 | $1.34 M | |
| 11/07/2022 | Q3 2022 | -$0.12 | -$0.11 | 0.01 | $1.81 M | |
| 08/12/2022 | Q2 2022 | -$0.12 | -$0.10 | 0.02 | $454,000 | |
| 05/13/2022 | Q1 2022 | -$0.11 | -$0.06 | 0.05 | $3.12 M | |
| 03/29/2022 | Q4 2021 | -$0.12 | -$0.11 | 0.01 | $0 | |
| 11/12/2021 | Q3 2021 | -$0.14 | $0 | |||
| 08/13/2021 | Q2 2021 | -$0.08 | $0 | |||
| 03/30/2021 | Q1 2021 | -$0.08 | $0 | |||
| 12/30/2020 | Q4 2020 | $0.07 | $4.10 M | |||
| 09/29/2020 | Q3 2020 | -$0.09 | $0 | |||
| 06/29/2020 | Q2 2020 | -$0.10 | $0 | |||
| 03/30/2020 | Q1 2020 | -$0.08 | $0 |
HCW Biologics Inc. Earnings: FAQ's
When is HCW Biologics Inc.'s earnings date?
HCW Biologics Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, April 1st, 2025 based off last year's report dates.
Did HCW Biologics Inc. beat their earnings estimates last
quarter?
In the previous quarter, HCW Biologics Inc. (:HCWB) reported $-0.1 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.13 by $0.03.
How can I listen to HCW Biologics Inc.'s earnings conference
call?
The conference call for HCW Biologics Inc.'s latest earnings report can be listened to online.
How can I read HCW Biologics Inc.'s conference call transcript?
The conference call transcript for HCW Biologics Inc.'s latest earnings report can be read online.
How much revenue does HCW Biologics Inc. generate each year?
HCW Biologics Inc. (:HCWB) has a recorded annual revenue of $2.84 M.
How much profit does HCW Biologics Inc. generate each year?
HCW Biologics Inc. (:HCWB) has a recorded net income of $2.84 M. HCW Biologics Inc. has generated $-0.7 earnings per share over the last four quarters.
What is HCW Biologics Inc.'s price-to-earnings ratio?
HCW Biologics Inc. (:HCWB) has a price-to-earnings ratio of -0.4 and price/earnings-to-growth ratio is -0.1.